Canada markets closed

Astellas Pharma Inc. (4503.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
1,892.50-32.00 (-1.66%)
At close: 3:15PM JST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-03-31
2020-03-31
2019-03-31
2018-03-31
Total Revenue
1,285,714,000
1,249,528,000
1,300,843,000
1,306,348,000
1,300,316,000
Cost of Revenue
251,250,000
246,063,000
276,739,000
292,050,000
294,250,000
Gross Profit
1,034,465,000
1,003,465,000
1,024,104,000
1,014,299,000
1,006,066,000
Operating Expenses
Research Development
231,849,000
224,489,000
224,226,000
208,682,000
220,781,000
Selling General and Administrative
532,687,000
504,316,000
499,295,000
490,263,000
478,330,000
Total Operating Expenses
896,172,000
867,892,000
778,452,000
768,760,000
790,388,000
Operating Income or Loss
138,293,000
135,573,000
245,652,000
245,539,000
215,678,000
Interest Expense
4,080,000
2,335,000
3,004,000
1,302,000
1,782,000
Income Before Tax
145,318,000
145,324,000
245,350,000
248,967,000
218,113,000
Income Tax Expense
25,957,000
24,734,000
49,939,000
26,702,000
53,434,000
Income from Continuing Operations
119,361,000
120,590,000
195,411,000
222,265,000
164,679,000
Net Income
119,360,000
120,589,000
195,411,000
222,265,000
164,679,000
Net Income available to common shareholders
119,360,000
120,589,000
195,411,000
222,265,000
164,679,000
Basic EPS
-
64.93
104.15
115.05
81.11
Diluted EPS
-
64.90
104.08
114.94
81.02
Basic Average Shares
-
1,857,125
1,876,193
1,931,882
2,030,203
Diluted Average Shares
-
1,858,193
1,877,548
1,933,748
2,032,472
EBITDA
-
220,311,000
314,750,000
313,727,000
284,758,000